US Patent Issued to INVOX PHARMA on June 10 for "Anti-mesothelin antibodies" (British Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,742, issued on June 10, was assigned to INVOX PHARMA Ltd. (London).

"Anti-mesothelin antibodies" was invented by Jose Munoz-Olaya (Cambridge, Great Britain), Remi Fertin (Cambridge, Great Britain), Francisca Wollerton (Cambridge, Great Britain), Mihriban Tuna (Cambridge, Great Britain) and Neil Brewis (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to antibody molecules that bind mesothelin (MSLN). The antibody molecules find application in the treatment and diagnosis of diseases and disorders, such as cancer."

The patent was filed on July 12, 2019, under Application No. 17/259,677.

*For fur...